Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat in Prehypertension
NCT01472692Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Oct 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of febuxostat in prehypertension, sponsored by University of California, San Diego. Primary endpoint: 24 Hour Blood Pressure at 8 weeks. Started Oct 2011; status: completed.
02
Drugs
febuxostat
03
Conditions
prehypertension
Beyond the preview
Go deeper on NCT01472692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472692.